Enhancing Alzheimer’s Diagnosis with Machine Learning on EEG: A Spectral Feature-Based Comparative Analysis

Background/Objectives: Alzheimer’s disease (AD) is a devastating neurodegenerative disorder that progressively impairs cognitive, neurological, and behavioral functions, severely affecting quality of life. The current diagnostic process relies on expert interpretation of extensive clinical assessments, often leading to delays that reduce the effectiveness of early interventions. Given the lack of a definitive cure, accelerating and improving diagnosis is critical to slowing disease progression. Electroencephalography (EEG), a widely used non-invasive technique, captures AD-related brain activity alterations, yet extracting meaningful features from EEG signals remains a significant challenge. This study introduces a machine learning (ML)-driven approach to enhance AD diagnosis using EEG data. Methods: EEG recordings from 36 AD patients, 23 Frontotemporal Dementia (FTD) patients, and 29 healthy individuals (HC) were analyzed. EEG signals were processed within the 0.5–45 Hz frequency range using the Welch method to compute the Power Spectral Density (PSD). From both the time-domain signals and the corresponding PSD, a total of 342 statistical and spectral features were extracted. The resulting feature set was then partitioned into training and test datasets while preserving the distribution of class labels. Feature selection was performed on the training set using Spearman and Pearson correlation analyses to identify the most informative features. To enhance classification performance, hyperparameter tuning was conducted using Bayesian optimization. Subsequently, classification was carried out using Support Vector Machines (SVMs) and k-Nearest Neighbors (k-NN) the optimized hyperparameters. Results: The SVM classifier achieved a notable accuracy of 96.01%, outperforming previously reported methods. Conclusions: These results demonstrate the potential of machine learning-based EEG analysis as an effective approach for the early diagnosis of Alzheimer’s Disease, enabling timely clinical intervention and ultimately contributing to improved patient outcomes.